Adbry® Treatment Resources & Videos | Adbry®

Step-by-step treatment routine

Watch Emma as she shows you how to self-inject Adbry® (tralokinumab-ldrm) in this step-by-step video.

Questions about self-injecting Adbry? Call the Adbry® Advocate™ Program at 844-MY-ADBRY (844-692-3279) for additional support from a Nurse Advocate.

Download Instructions for Use in English

Download Instructions for Use in Spanish

Real stories. Real people. Real results with Adbry.

Hear from Beth and Kalvin, 2 Adbry® Voices™ ambassadors, as they share their experience with moderate-to-severe and their treatment journey with Adbry. Individual results may vary.

What you can expect with Adbry

Find information to help you get started on treatment, including an overview of how Adbry was studied, how it works, what resources are available to you, and more.

To receive an Adbry Welcome Pack, which includes an Adbry , contact the Adbry® Advocate™ Program at 844-MY-ADBRY (844-692-3279).

Download the guide

Graphic of the guide to starting Adbry™ (tralokinumab-ldrm) brochure

Stay on track with the Adbry Digital Companion

We partnered with Medisafe®, a top-rated medication management app, to create the Adbry Digital Companion. This free-to-use app delivers medication reminders in real time, educational content, and 1-on-1 Adbry Nurse Advocate support right to your smart device.

Once your healthcare professional prescribes Adbry, download the Medisafe app from your app store and add Adbry to your digital medicine cabinet.

Adbry Medisafe Apple App Store

Adbry Medisafe Google Play

App Store is a service mark of Apple Inc., registered in the U.S. and other countries. Google Play and the Google Play logo are trademarks of Google LLC. Medisafe is a registered trademark of Medisafe Project LTD.

Graphic of Medisafe App Screen on Mobile Phone

Keep learning about Adbry:

What is Adbry?

Learn how it works

Adbry clinical results

See what’s possible

Savings programs

Find support options

INDICATION AND IMPORTANT SAFETY INFORMATION

Read more Collapse

What is ADBRY?

ADBRY® (tralokinumab-ldrm) injection is a prescription medicine used to treat adults with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. ADBRY can be used with or without topical corticosteroids.
It is not known if ADBRY is safe and effective in children.

Do not use ADBRY if you are allergic to tralokinumab or to any of its ingredients.

What should I discuss with my healthcare provider before starting ADBRY?

Tell your healthcare provider about all your medical conditions, including if you:

have eye problems.
have a parasitic (helminth) infection.
are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with ADBRY.
are pregnant or plan to become pregnant. It is not known whether ADBRY will harm your unborn baby. There is a pregnancy exposure registry for women who use ADBRY during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. If you are pregnant or become pregnant while taking ADBRY, you are encouraged to enroll in the registry. You or your healthcare provider can get information and enroll you in this registry by calling 1-877-311-8972 or visiting https://mothertobaby.org/ongoing-study/adbry-tralokinumab.
are breastfeeding or plan to breastfeed. It is not known whether ADBRY passes into your breast milk and if it can harm your baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use ADBRY?

See the detailed “Instructions for Use” that comes with ADBRY for information on how to prepare and inject ADBRY and how to properly store and throw away (dispose of) used ADBRY prefilled syringes.
Use ADBRY exactly as prescribed by your healthcare provider.
Your healthcare provider will tell you how much ADBRY to inject and when to inject it.
ADBRY comes as a single-dose (150 mg) prefilled syringe with needle guard.
ADBRY is given as an injection under the skin (subcutaneous injection).
If your healthcare provider decides that you or a caregiver can give the injection of ADBRY, you or your caregiver should receive training on the right way to prepare and inject ADBRY. Do not try to inject ADBRY until you have been shown the right way by your healthcare provider.
If you miss a dose, inject the missed dose as soon as possible, then continue with your next dose at your regular scheduled time.
If you inject more ADBRY than prescribed, call Poison Control at 1-800-222-1222.
Your healthcare provider may prescribe other medicines to use with ADBRY. Use the other prescribed medicines exactly as your healthcare provider tells you to.

What are the possible side effects of ADBRY?

ADBRY can cause serious side effects, including:

Allergic reactions (hypersensitivity), including a severe reaction known as anaphylaxis. Stop using ADBRY and tell your healthcare provider or get emergency help right away if you get any of the following symptoms:
- breathing problems
- itching
- skin rash
- swelling of the face, mouth, and tongue
- fainting, dizziness, feeling lightheaded (low blood pressure)
- hives

Eye problems. Tell your healthcare provider if you have any worsening eye problems, including eye pain or changes in vision.

The most common side effects of ADBRY include:

Eye and eyelid inflammation, including redness, swelling, and itching
Injection site reactions
High count of a certain white blood cell (eosinophilia)

These are not all of the possible side effects of ADBRY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see Full Prescribing Information, including Patient Information and Instructions for Use.